Martin E Adelson

Title: Martin E Adelson: Innovator in Lentiviral Vector Production

Introduction

Martin E Adelson is a notable inventor based in Hillsborough, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the development of novel packaging cell lines for lentiviral vectors. His work has implications for both in vitro screening assays and gene therapy applications.

Latest Patents

Adelson holds a patent for "Inducible packaging cell lines for lentivirus vectors." This patent discloses innovative packaging cell lines that utilize an ecdysone-inducible system for virus production. This system effectively avoids the cytotoxic effects associated with the unregulated expression of certain envelope proteins and lentiviral proteins. The various embodiments of these cell lines are designed to cater to different purposes, ranging from laboratory assays to therapeutic applications in vivo.

Career Highlights

Martin E Adelson is affiliated with the University of Medicine and Dentistry of New Jersey, where he has been able to apply his expertise in biotechnology. His work has been instrumental in advancing the understanding and production of lentiviral vectors, which are crucial for various medical applications.

Collaborations

Adelson has collaborated with notable colleagues, including Joseph P Dougherty and Malvika Kaul. These collaborations have further enriched his research and contributed to the advancements in the field of gene therapy.

Conclusion

Martin E Adelson's innovative work in the development of inducible packaging cell lines for lentiviral vectors showcases his significant contributions to biotechnology. His research continues to pave the way for advancements in gene therapy and related fields.